サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1363067

消化管滞留型ドラッグデリバリーシステムアウトソーシングの市場規模、シェア、動向分析レポート：剤形別、地域別、セグメント別予測、2023年～2030年

Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
消化管滞留型ドラッグデリバリーシステムアウトソーシングの市場規模、シェア、動向分析レポート：剤形別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月18日
発行: Grand View Research
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

消化管滞留型ドラッグデリバリーシステムアウトソーシング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の消化管滞留型ドラッグデリバリーシステムアウトソーシング市場規模は2030年までに22億7,000万米ドルに達する見込みです。

同市場は2023年から2030年にかけてCAGR 6.99％で拡大する見込みです。患者中心のソリューションへの注目の高まりとアウトソーシング需要の拡大は、市場拡大を促進する主な要因の一部です。さらに、局所ドラッグデリバリーへの注目の高まりが市場成長を後押しすると予想されます。

消化管滞留型ドラッグデリバリーシステムは、消化管内の局所的なドラッグデリバリー用途に適応されます。これは特に消化性潰瘍、胃食道逆流症（GERD）、炎症性腸疾患（IBD）などの疾患に当てはまる。さらに、薬物送達の精度、モニタリング、患者の関与を向上させるために、ナノテクノロジー、3Dプリンティング、デジタルヘルスなどの先端技術を胃内滞留性ドラッグデリバリーシステムに利用することが研究されています。

COVID-19の大流行は、消化管滞留型ドラッグデリバリーシステムアウトソーシング市場に大きな影響を与えました。戸締まり、渡航制限、患者募集の問題により、多くの臨床試験が延期または遅延しました。このため、新規の胃内滞留性薬物送達システムの開発と試験が妨げられました。さらに、パンデミックは世界のサプライチェーンを混乱させ、原材料や工業部品の入手を困難にしました。この要因は消化管滞留型ドラッグデリバリーシステムの製造と開発に影響を与えました。

新製品の発売、提携、主要事業会社による合併・買収、研究開発プログラムへの投資の増加といった戦略的イニシアチブの高まりといった要因も、今後数年間の市場成長を後押しすると予想されます。例えば、ロンザは2022年11月、腸内ドラッグデリバリー用に設計された新しいカプセルソリューション「Capsugel Enprotect」を発表しました。従来のカプセルとは異なり、この革新的なデザインは胃の通過中もそのままで、腸で内容物のみを放出します。カプシュゲル・エンプロテクトはコーティングを必要としないカプセルで、カプセルのコーティングや封をする必要がないため、医薬品の製造工程を簡素化できる可能性があります。

消化管滞留型ドラッグデリバリーシステムアウトソーシング市場レポート・ハイライト

  • 剤形別では、錠剤セグメントが2022年に38%超の最大売上シェアを占めました。錠剤はよく知られ、広く使用されている剤形です。錠剤はその適応性の高さから、放出制御、徐放、標的投与など様々な製剤方法に用いることができ、胃内滞留性ドラッグデリバリーシステムに最適です。
  • カプセルは、予測期間において大きな市場シェアを占めると予想されます。調節放出や特殊コーティングなどのカプセル技術の開発により、より高度な胃内滞留性組成物の開発が可能になります。こうした進歩により、カプセルをベースとした薬物送達システムを中心としたアウトソーシングサービスの需要が高まる可能性があります。
  • 北米は2022年に47%を超える最大の売上シェアを獲得しました。これは、同地域の先進的な製薬産業、強力な研究開発能力、高い市場需要、確立されたヘルスケアインフラに起因します。
  • 一方、アジア太平洋地域は今後数年間、市場収益に大きく貢献すると予想されます。費用対効果の高いアウトソーシング、政府の支援とインセンティブ、ヘルスケアニーズの高まり、技術の進歩などが、この地域の市場成長を促進する主な要因となっています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 事業環境分析
    • PESTLE分析
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 剤形ビジネス分析

  • 消化管滞留型ドラッグデリバリーシステムアウトソーシング：剤形別変動分析、2022年および2030年
  • 錠剤
  • リキッド
  • ミクロスフェア
  • カプセル
  • その他

第5章 地域別ビジネス分析

  • 地域市場のスナップショット
  • 北米
    • 北米の消化管滞留型ドラッグデリバリーシステムアウトソーシング市場、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の消化管滞留型ドラッグデリバリーシステムアウトソーシング市場、2018年から2030年
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域の消化管滞留型ドラッグデリバリーシステムアウトソーシング市場、2018年から2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ラテンアメリカの消化管滞留型ドラッグデリバリーシステムアウトソーシング市場、2018年から2030年
    • 主要な国の動向
    • 規制の枠組み
    • 競合シナリオ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA消化管滞留型ドラッグデリバリーシステムアウトソーシング市場、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 買収
    • コラボレーション
    • 新しいプラットフォームの発表
    • その他
  • 企業プロファイル・一覧表
    • Catalent
    • Lonza
    • Evonik
    • Colorcon
    • Quotient Sciences
    • Aptar Pharma
    • Aenova Group
    • Evotec
    • Ashland
    • Vectura Group Ltd.
図表

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 4 Global Gastroretentive Drug Delivery Systems Outsourcing Market by Region, 2018 - 2030 (USD Million)
  • Table 5 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 6 North America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 7 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 8 Canada Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 9 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 10 Europe Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 11 Germany Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 12 UK Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 13 France Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 14 Italy Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 15 Spain Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 16 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 17 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 18 Norway Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 21 China Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 22 Japan Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 23 India Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 24 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 25 Australia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 26 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 27 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 28 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 29 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 30 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 31 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 34 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 36 UAE Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)
  • Table 37 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market by Dosage Forms, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Gastroretentive Drug Delivery Systems Outsourcing Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 Penetration & Growth Prospect Mapping
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 14 Regional Marketplace: Key Takeaways
  • Fig. 15 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Tablets,2018 - 2030 (USD Million)
  • Fig. 16 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Liquid,2018 - 2030 (USD Million)
  • Fig. 17 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Microspheres,2018 - 2030 (USD Million)
  • Fig. 18 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Capsule,2018 - 2030 (USD Million)
  • Fig. 19 Global Gastroretentive Drug Delivery Systems Outsourcing Market for Others,2018 - 2030 (USD Million)
  • Fig. 20 Regional Outlook, 2021 & 2030
  • Fig. 21 North America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 22 U.S. Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 23 Canada Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 24 Europe Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 25 Germany Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 26 UK Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 27 France Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 28 Italy Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 29 Spain Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 30 Denmark Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 31 Sweden Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 32 Norway Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 33 Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 34 Japan Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 35 China Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 36 India Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 37 Australia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 38 South Korea Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 39 Thailand Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 40 Latin America Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 41 Brazil Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 42 Mexico Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 43 Argentina Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 44 Middle East and Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 45 South Africa Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 46 Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 47 UAE Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
  • Fig. 48 Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-122-6

Gastroretentive Drug Delivery Systems Outsourcing Market Growth & Trends:

The global gastroretentive drug delivery systems outsourcing market size is expected to reach USD 2.27 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 6.99% from 2023 to 2030. Rising focus on patient-centric solutions and growing outsourcing demand are some of the key factors driving market expansion. Furthermore, an increased focus on localized drug delivery is expected to boost market growth.

Gastroretentive drug delivery systems are indicated for localized drug delivery applications in the gastrointestinal tract. This is particularly true for disorders such as peptic ulcers, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD). Moreover, the use of advanced technologies such as nanotechnology, 3D printing, and digital health in gastroretentive drug delivery systems has been investigated in order to improve drug delivery accuracy, monitoring, and patient involvement.

The COVID-19 pandemic significantly impacted the market for gastroretentive drug delivery systems outsourcing. Many clinical trials were postponed or delayed as a result of lockdowns, travel restrictions, and patient recruitment issues. This hampered the development and testing of novel gastroretentive medication delivery systems. Moreover, the pandemic disrupted worldwide supply chains, disrupting the availability of raw materials and industrial components. This factor had an influence on the manufacturing and development of gastroretentive drug delivery systems.

Factors such as rising strategic initiatives in the form of new product launches, partnerships, mergers & acquisitions by key operating companies, and growing investments in R&D programs are other factors expected to boost market growth in the coming years. For instance, in November 2022, Lonza introduced a new capsule solution known as Capsugel Enprotect, designed for intestinal drug delivery. Unlike conventional capsules, this innovative design remains intact during stomach transit and only releases its contents in the intestine. Capsugel Enprotect is a coating-free capsule that could potentially simplify the drug manufacturing process by eliminating the need for additional capsule coating or sealing.

Gastroretentive Drug Delivery Systems Outsourcing Market Report Highlights:

  • Based on dosage form, the tablets segment accounted for the largest revenue share of over 38% in 2022. Tablets are a well-known and extensively used dosage type. Because of their adaptability, they can be used in various formulation methods, such as controlled release, sustained release, and targeted administration, making them ideal for gastroretentive drug delivery systems
  • The capsule segment is expected to account for a significant market share in the forecast period. Capsule technology developments, such as modulated release and specialized coatings, enable the development of more advanced gastroretentive compositions. These advancements may enhance the demand for outsourcing services centered on capsule-based medication delivery systems
  • North America captured the largest revenue share of over 47% in 2022. This is attributed to the region's advanced pharmaceutical industry, strong research and development capabilities, high market demand, and an established healthcare infrastructure
  • On the other hand, the Asia Pacific region is expected to contribute significantly to the market revenue in the coming years. Cost-effective outsourcing, government support and incentives, rising healthcare needs, and technological advancements are some of the major factors driving the regional market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Dosage Form Business Analysis

  • 4.1. Gastroretentive Drug Delivery Systems Outsourcing: Dosage Form Movement Analysis, 2022 & 2030
  • 4.2. Tablets
    • 4.2.1. Tablets Market, 2018 - 2030 (USD Million)
  • 4.3. Liquid
    • 4.3.1. Liquid Market, 2018 - 2030 (USD Million)
  • 4.4. Microspheres
    • 4.4.1. Microspheres Market, 2018 - 2030 (USD Million)
  • 4.5. Capsule
    • 4.5.1. Capsule Market, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.2.2. Key Country Dynamics
      • 5.2.2.3. Regulatory Framework
      • 5.2.2.4. Competitive Scenario
    • 5.2.3. Canada
      • 5.2.3.1. Canada Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.2.3.2. Key Country Dynamics
      • 5.2.3.3. Regulatory Framework
      • 5.2.3.4. Competitive Scenario
  • 5.3. Europe
    • 5.3.1. Europe Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.3.2. Germany
      • 5.3.2.1. Germany Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.2.2. Key Country Dynamics
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Competitive Scenario
    • 5.3.3. UK
      • 5.3.3.1. UK Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.3.2. Key Country Dynamics
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Competitive Scenario
    • 5.3.4. France
      • 5.3.4.1. France Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.4.2. Key Country Dynamics
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Competitive Scenario
    • 5.3.5. Italy
      • 5.3.5.1. Italy Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.5.2. Key Country Dynamics
      • 5.3.5.3. Regulatory Framework
      • 5.3.5.4. Competitive Scenario
    • 5.3.6. Spain
      • 5.3.6.1. Spain Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.6.2. Key Country Dynamics
      • 5.3.6.3. Regulatory Framework
      • 5.3.6.4. Competitive Scenario
    • 5.3.7. Denmark
      • 5.3.7.1. Denmark Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.7.2. Key Country Dynamics
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Competitive Scenario
    • 5.3.8. Sweden
      • 5.3.8.1. Sweden Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.8.2. Key Country Dynamics
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Competitive Scenario
    • 5.3.9. Norway
      • 5.3.9.1. Norway Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.3.9.2. Key Country Dynamics
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Competitive Scenario
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Japan Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.2.2. Key Country Dynamics
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Competitive Scenario
    • 5.4.3. China
      • 5.4.3.1. China Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.3.2. Key Country Dynamics
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Competitive Scenario
    • 5.4.4. India
      • 5.4.4.1. India Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.4.2. Key Country Dynamics
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Competitive Scenario
    • 5.4.5. South Korea
      • 5.4.5.1. South Korea Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.5.2. Key Country Dynamics
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Competitive Scenario
    • 5.4.6. Australia
      • 5.4.6.1. Australia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.6.2. Key Country Dynamics
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Competitive Scenario
    • 5.4.7. Thailand
      • 5.4.7.1. Thailand Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.4.7.2. Key Country Dynamics
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Competitive Scenario
  • 5.5. Latin America
    • 5.5.1. Latin America Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.5.2. Key Country Dynamics
    • 5.5.3. Regulatory Framework
    • 5.5.4. Competitive Scenario
    • 5.5.5. Brazil
      • 5.5.5.1. Brazil Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.5.2. Key Country Dynamics
      • 5.5.5.3. Regulatory Framework
      • 5.5.5.4. Competitive Scenario
    • 5.5.6. Mexico
      • 5.5.6.1. Mexico Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.6.2. Key Country Dynamics
      • 5.5.6.3. Regulatory Framework
      • 5.5.6.4. Competitive Scenario
    • 5.5.7. Argentina
      • 5.5.7.1. Argentina Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.5.7.2. Key Country Dynamics
      • 5.5.7.3. Regulatory Framework
      • 5.5.7.4. Competitive Scenario
  • 5.6. MEA
    • 5.6.1. MEA Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. South Africa Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.2.2. Key Country Dynamics
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Competitive Scenario
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Saudi Arabia Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.3.2. Key Country Dynamics
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Competitive Scenario
    • 5.6.4. UAE
      • 5.6.4.1. UAE Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.4.2. Key Country Dynamics
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Competitive Scenario
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Gastroretentive Drug Delivery Systems Outsourcing Market, 2018 - 2030 (USD Million)
      • 5.6.5.2. Key Country Dynamics
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Competitive Scenario

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
    • 6.2.1. Acquisitions
    • 6.2.2. Collaborations
    • 6.2.3. New Platform Launches
    • 6.2.4. Others
  • 6.3. Company Profiles/Listing
    • 6.3.1. Catalent
      • 6.3.1.1. Company Overview
      • 6.3.1.2. Financial Performance
      • 6.3.1.3. Platform Benchmarking
      • 6.3.1.4. Strategic Initiatives
    • 6.3.2. Lonza
      • 6.3.2.1. Company Overview
      • 6.3.2.2. Financial Performance
      • 6.3.2.3. Platform Benchmarking
      • 6.3.2.4. Strategic Initiatives
    • 6.3.3. Evonik
      • 6.3.3.1. Company Overview
      • 6.3.3.2. Financial Performance
      • 6.3.3.3. Platform Benchmarking
      • 6.3.3.4. Strategic Initiatives
    • 6.3.4. Colorcon
      • 6.3.4.1. Company Overview
      • 6.3.4.2. Financial Performance
      • 6.3.4.3. Platform Benchmarking
      • 6.3.4.4. Strategic Initiatives
    • 6.3.5. Quotient Sciences
      • 6.3.5.1. Company Overview
      • 6.3.5.2. Financial Performance
      • 6.3.5.3. Platform Benchmarking
      • 6.3.5.4. Strategic Initiatives
    • 6.3.6. Aptar Pharma
      • 6.3.6.1. Company Overview
      • 6.3.6.2. Financial Performance
      • 6.3.6.3. Platform Benchmarking
      • 6.3.6.4. Strategic Initiatives
    • 6.3.7. Aenova Group
      • 6.3.7.1. Company Overview
      • 6.3.7.2. Financial Performance
      • 6.3.7.3. Platform Benchmarking
      • 6.3.7.4. Strategic Initiatives
    • 6.3.8. Evotec
      • 6.3.8.1. Company Overview
      • 6.3.8.2. Financial Performance
      • 6.3.8.3. Platform Benchmarking
      • 6.3.8.4. Strategic Initiatives
    • 6.3.9. Ashland
      • 6.3.9.1. Company Overview
      • 6.3.9.2. Financial Performance
      • 6.3.9.3. Platform Benchmarking
      • 6.3.9.4. Strategic Initiatives
    • 6.3.10. Vectura Group Ltd.
      • 6.3.10.1. Company Overview
      • 6.3.10.2. Financial Performance
      • 6.3.10.3. Platform Benchmarking
      • 6.3.10.4. Strategic Initiatives